Consensus Core Laboratories Inc.

Stocks

CLB

US21867A1051

Business Support Services

Real-time Estimate Cboe BZX 11:17:34 2026-10-20 am EDT			5-day change	1st Jan Change
10.02 ^USD	-1.23%		-0.84%	-37.15%

Aug. 25	Core Laboratories Inc. Announces Resignation of Kwaku Temeng as Director, Chairman of the Nominating Committee and as A Member of the Compensation Committee, Effective October 1, 2026	CI
Jul. 30	Core Laboratories Inc., Q2 2026 Earnings Call, Jul 30, 2026

Evolution of the Average Target: Core Laboratories Inc.

Evolution of the Target Price: Core Laboratories Inc.

Changes in Analyst Recommendations: Core Laboratories Inc.

2b66c3.5XD7EVwnFLHpkoVh9v0ZM98BXWJ61DxlMkWUkheJaZs.1zrKIg0Tf-bE_NMiosp9RKp0NlUTvUgpWSek9nq-Md-yIrFWEEIh9q7FzA~228cc64dd91c568b0127575782026569

Analysts' recommendations: Core Laboratories Inc.

Jul. 15	BofA Securities Adjusts Core Laboratories Price Target to $11 From $12	MT
25-03-12	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15	MT
25-03-06	Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating	MT
24-10-25	The Zephirin Group Upgrades Core Laboratories to Buy from Hold; Adjusts Price Target to $22 from $18	MT
24-10-25	Zephirin Group Upgrades Core Laboratories to Buy Medium Risk From Hold Medium Risk, Raises Price Target to $22 From $18	MT
24-07-15	Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating	MT
24-01-29	Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	MT
23-09-18	Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	MT
23-07-31	Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	MT
23-06-30	Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22	MT
23-05-01	Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target	MT
23-05-01	Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating	MT
23-04-28	Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating	MT
23-04-18	BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50	MT
23-02-07	Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating	MT
23-01-09	BofA Securities Upgrades Core Laboratories to Neutral From Underperform	MT
22-10-07	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24	MT
22-09-26	Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target	MT
22-08-02	Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating	MT
22-08-01	Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating	MT
22-07-15	BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating	MT
22-07-13	Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating	MT
22-07-13	Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating	MT
22-05-02	Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating	MT
22-04-18	Piper Sandler Downgrades Core Laboratories to Underweight From Neutral	MT

More recommendations

Testing Laboratories

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CORE LABORATORIES INC.					+47.78%
	VISA, INC.					+4.93%
	CINTAS CORPORATION					+2.83%
	UNITED RENTALS, INC.					+23.03%
	PAYPAL HOLDINGS, INC.					+0.4%
	BLOCK, INC.					+26.28%
	NEBIUS GROUP					+66.59%
	SUNBELT RENTALS HOLDINGS, INC.					+16.86%
	CORPAY, INC.					+14.52%
	FISERV, INC.					+21.94%
	Average					+22.52%
	Weighted average by Cap.					+10.06%